TSX-V:NSCI - TSX Venture Exchange - CA63000Y1034 - Common Stock - Currency: CAD
TSX-V:NSCI (3/7/2025, 7:00:00 PM)
0.3
0 (0%)
The current stock price of NSCI.CA is 0.3 CAD. In the past month the price decreased by -3.23%. In the past year, price decreased by -29.41%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta and currently employs 130 full-time employees. The company went IPO on 2017-06-29. The Company’s segments include Scientific Equipment and Security Services. Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology Company that develops, manufactures, and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. Security Services, focuses on providing security services, namely providing preventative and oncall maintenance services, as well as installation, of detection and analysis equipment. The company offers commercial security equipment installation and maintenance services to a variety of customers in North America. The company provides airport security equipment maintenance services in each province and territory of Canada.
NANALYSIS SCIENTIFIC CORP
Unit 105, 90 Freeport Boulevard NE
Calgary ALBERTA T2E 7C3 CA
CEO: Sean Krakiwsky
Employees: 249
Company Website: https://www.nanalysis.com/nsci-overview
Investor Relations: http://www.nanalysis.com/investor-relations
Phone: 14037699499
The current stock price of NSCI.CA is 0.3 CAD.
The exchange symbol of NANALYSIS SCIENTIFIC CORP is NSCI and it is listed on the TSX Venture Exchange exchange.
NSCI.CA stock is listed on the TSX Venture Exchange exchange.
6 analysts have analysed NSCI.CA and the average price target is 1.07 CAD. This implies a price increase of 257% is expected in the next year compared to the current price of 0.3. Check the NANALYSIS SCIENTIFIC CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) has a market capitalization of 33.97M CAD. This makes NSCI.CA a Nano Cap stock.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) currently has 249 employees.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) has a resistance level at 0.3. Check the full technical report for a detailed analysis of NSCI.CA support and resistance levels.
The Revenue of NANALYSIS SCIENTIFIC CORP (NSCI.CA) is expected to grow by 57.15% in the next year. Check the estimates tab for more information on the NSCI.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NSCI.CA does not pay a dividend.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) will report earnings on 2025-04-28, after the market close.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.16).
ChartMill assigns a fundamental rating of 3 / 10 to NSCI.CA. NSCI.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NSCI.CA reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -60% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -16.71% | ||
ROE | -36.72% | ||
Debt/Equity | 0.61 |
ChartMill assigns a Buy % Consensus number of 80% to NSCI.CA. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 65.28% and a revenue growth 57.15% for NSCI.CA